Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

NCT02057172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HM11260C
DRUG: liraglutide
DRUG: Placebo

Sponsor

Hanmi Pharmaceutical Company Limited